These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 27181729)
1. [Is the regulation of immune system in Alzheimer's disease effective? ]. Shirakawa H Nihon Yakurigaku Zasshi; 2016 May; 147(5):319. PubMed ID: 27181729 [No Abstract] [Full Text] [Related]
2. The role of the immune system in Alzheimer disease: Etiology and treatment. Jevtic S; Sengar AS; Salter MW; McLaurin J Ageing Res Rev; 2017 Nov; 40():84-94. PubMed ID: 28941639 [TBL] [Abstract][Full Text] [Related]
3. Microglia in Alzheimer's disease: A target for immunotherapy. Wang S; Colonna M J Leukoc Biol; 2019 Jul; 106(1):219-227. PubMed ID: 30725482 [TBL] [Abstract][Full Text] [Related]
4. Is 'friendly fire' in the brain provoking Alzheimer's disease? Abbott A Nature; 2018 Apr; 556(7702):426-428. PubMed ID: 29691517 [No Abstract] [Full Text] [Related]
5. Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease. Lewcock JW; Schlepckow K; Di Paolo G; Tahirovic S; Monroe KM; Haass C Neuron; 2020 Dec; 108(5):801-821. PubMed ID: 33096024 [TBL] [Abstract][Full Text] [Related]
6. Inflammation of the brain in Alzheimer's disease: implications for therapy. McGeer PL; McGeer EG J Leukoc Biol; 1999 Apr; 65(4):409-15. PubMed ID: 10204568 [TBL] [Abstract][Full Text] [Related]
7. Immunology and immunotherapy of Alzheimer's disease. Weiner HL; Frenkel D Nat Rev Immunol; 2006 May; 6(5):404-16. PubMed ID: 16639431 [TBL] [Abstract][Full Text] [Related]
8. Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies. Liu YH; Zeng F; Wang YR; Zhou HD; Giunta B; Tan J; Wang YJ Drug Discov Today; 2013 Dec; 18(23-24):1212-20. PubMed ID: 23954180 [TBL] [Abstract][Full Text] [Related]
9. [Inflammation and Alzheimer's disease]. de Toledo M Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061 [TBL] [Abstract][Full Text] [Related]
10. Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease. Song F; Qian Y; Peng X; Han G; Wang J; Bai Z; Crack PJ; Lei H Curr Opin Pharmacol; 2016 Feb; 26():47-53. PubMed ID: 26480202 [TBL] [Abstract][Full Text] [Related]
11. A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer's Disease. Schwartz M; Peralta Ramos JM; Ben-Yehuda H J Immunol; 2020 Jan; 204(2):243-250. PubMed ID: 31907265 [TBL] [Abstract][Full Text] [Related]
12. The immune system, amyloid-beta peptide, and Alzheimer's disease. Weksler ME; Gouras G; Relkin NR; Szabo P Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358 [TBL] [Abstract][Full Text] [Related]
13. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice. Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for Alzheimer's disease. Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646 [TBL] [Abstract][Full Text] [Related]